Lista de obras - Carine Ali - Dominio Público Uruguay

2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo

artículo científico publicado en 2004

A Transforming Growth Factor-β Antagonist Unmasks the Neuroprotective Role of This Endogenous Cytokine in Excitotoxic and Ischemic Brain Injury

scientific article published on 01 December 1999

ADAMTS-4 in oligodendrocytes contributes to myelination with an impact on motor function.

artículo científico publicado en 2017

Activation of cell surface GRP78 decreases endoplasmic reticulum stress and neuronal death.

artículo científico publicado en 2017

Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain

artículo científico publicado en 2012

Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact

artículo científico publicado en 2009

Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin

artículo científico publicado en 2008

Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory.

artículo científico publicado en 2007

Antibodies preventing the interaction of tissue-type plasminogen activator with N-methyl-D-aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis.

artículo científico publicado en 2011

Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling

artículo científico publicado en 2004

Distal occlusion of the middle cerebral artery in mice: are we ready to assess long-term functional outcome?

artículo científico

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation

artículo científico publicado en 2007

Functional occurrence of the interaction of tissue plasminogen activator with the NR1 Subunit of N-methyl-D-aspartate receptors during stroke

artículo científico publicado en 2010

GluN2D subunit-containing NMDA receptors control tissue plasminogen activator-mediated spatial memory.

artículo científico publicado en 2012

HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator

artículo científico publicado en 2011

High t-PA release by neonate brain microvascular endothelial cells under glutamate exposure affects neuronal fate

artículo científico publicado en 2012

Immunotherapy blocking the tissue plasminogen activator-dependent activation of N-methyl-D-aspartate glutamate receptors improves hemorrhagic stroke outcome

artículo científico publicado en 2012

Impact of alcohol consumption on the outcome of ischemic stroke and thrombolysis: role of the hepatic clearance of tissue-type plasminogen activator.

artículo científico publicado en 2015

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival

artículo científico publicado en 2015

Ischemia-Induced Interleukin-6 as a Potential Endogenous Neuroprotective Cytokine against NMDA Receptor-Mediated Excitoxicity in the Brain

artículo científico publicado en 2000

Longitudinal Molecular Magnetic Resonance Imaging of Endothelial Activation after Severe Traumatic Brain Injury

artículo científico publicado en 2019

Memantine improves safety of thrombolysis for stroke

artículo científico publicado en 2012

Molecular magnetic resonance imaging discloses endothelial activation after transient ischaemic attack

artículo científico publicado en 2016

NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production.

artículo científico publicado en 2005

NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity

artículo científico publicado en 2009

NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.

artículo científico publicado en 2014

Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics.

artículo científico publicado en 2006

Neuroprotection and stroke: time for a compromise

artículo científico publicado en 2007

Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway.

artículo científico publicado en 2001

Neurotrophin-3-induced PI-3 kinase/Akt signaling rescues cortical neurons from apoptosis

artículo científico publicado en 2004

Newborn- and adult-derived brain microvascular endothelial cells show age-related differences in phenotype and glutamate-evoked protease release

artículo científico publicado en 2009

PPACK-Desmodus rotundus salivary plasminogen activator (cDSPAα1) prevents the passage of tissuetype plasminogen activator (rt-PA) across the blood-brain barrier and neurotoxicity

artículo científico publicado en 2009

Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults

artículo científico publicado en 2011

Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP.

artículo científico publicado en 2011

Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi

artículo científico publicado en 2017

Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects

artículo científico publicado en 2007

Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo

artículo científico publicado en 2011

Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis

artículo científico publicado en 2002

Stressed neurons protect themselves by a tissue-type plasminogen activator-mediated EGFR-dependent mechanism

artículo científico publicado en 2015

Stroke and the immune system: from pathophysiology to new therapeutic strategies

artículo científico publicado en 2011

The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo

artículo científico publicado en 2005

The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management?

artículo científico publicado en 2004

The plasminogen activation system in neuroinflammation

artículo científico publicado en 2015

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

artículo científico publicado en 2001

The role of plasminogen activators in stroke treatment: fibrinolysis and beyond

scientific article published on 13 November 2018

Tissue plasminogen activator prevents white matter damage following stroke

artículo científico publicado en 2011

Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors.

artículo científico publicado en 2016

Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis

artículo científico publicado en 2005

Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.

artículo científico publicado en 2008

Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity

artículo científico publicado en 2006

Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity.

artículo científico publicado en 2008

Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity.

artículo científico publicado en 2002

Transforming growth factor-beta and ischemic brain injury ⬇️

artículo científico publicado el 1 de octubre de 2003

Transforming growth factor-beta signalling in brain disorders

artículo científico publicado en 2005

Traumatic brain injury: tissue-type plasminogen activator--harmful or beneficial?

artículo científico publicado en 2012

Understanding the functions of endogenous and exogenous tissue-type plasminogen activator during stroke

artículo científico publicado en 2014

VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation

artículo científico publicado en 2011

tPA in the injured central nervous system: different scenarios starring the same actor?

artículo científico publicado en 2011

Lista de obras de Carine Ali

2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo

A Transforming Growth Factor-β Antagonist Unmasks the Neuroprotective Role of This Endogenous Cytokine in Excitotoxic and Ischemic Brain Injury

ADAMTS-4 in oligodendrocytes contributes to myelination with an impact on motor function.

Activation of cell surface GRP78 decreases endoplasmic reticulum stress and neuronal death.

Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain

Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact

Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin

Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory.

Antibodies preventing the interaction of tissue-type plasminogen activator with N-methyl-D-aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis.

Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling

Distal occlusion of the middle cerebral artery in mice: are we ready to assess long-term functional outcome?

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation

Functional occurrence of the interaction of tissue plasminogen activator with the NR1 Subunit of N-methyl-D-aspartate receptors during stroke

GluN2D subunit-containing NMDA receptors control tissue plasminogen activator-mediated spatial memory.

HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator

High t-PA release by neonate brain microvascular endothelial cells under glutamate exposure affects neuronal fate

Immunotherapy blocking the tissue plasminogen activator-dependent activation of N-methyl-D-aspartate glutamate receptors improves hemorrhagic stroke outcome

Impact of alcohol consumption on the outcome of ischemic stroke and thrombolysis: role of the hepatic clearance of tissue-type plasminogen activator.

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival

Ischemia-Induced Interleukin-6 as a Potential Endogenous Neuroprotective Cytokine against NMDA Receptor-Mediated Excitoxicity in the Brain

Longitudinal Molecular Magnetic Resonance Imaging of Endothelial Activation after Severe Traumatic Brain Injury

Memantine improves safety of thrombolysis for stroke

Molecular magnetic resonance imaging discloses endothelial activation after transient ischaemic attack

NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production.

NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity

NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.

Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics.

Neuroprotection and stroke: time for a compromise

Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway.

Neurotrophin-3-induced PI-3 kinase/Akt signaling rescues cortical neurons from apoptosis

Newborn- and adult-derived brain microvascular endothelial cells show age-related differences in phenotype and glutamate-evoked protease release

PPACK-Desmodus rotundus salivary plasminogen activator (cDSPAα1) prevents the passage of tissuetype plasminogen activator (rt-PA) across the blood-brain barrier and neurotoxicity

Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults

Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP.

Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi

Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects

Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo

Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis

Stressed neurons protect themselves by a tissue-type plasminogen activator-mediated EGFR-dependent mechanism

Stroke and the immune system: from pathophysiology to new therapeutic strategies

The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo

The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management?

The plasminogen activation system in neuroinflammation

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

The role of plasminogen activators in stroke treatment: fibrinolysis and beyond

Tissue plasminogen activator prevents white matter damage following stroke

Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors.

Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis

Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.

Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity

Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity.

Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity.

Transforming growth factor-beta and ischemic brain injury ⬇️

Transforming growth factor-beta signalling in brain disorders

Traumatic brain injury: tissue-type plasminogen activator--harmful or beneficial?

Understanding the functions of endogenous and exogenous tissue-type plasminogen activator during stroke

VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation

tPA in the injured central nervous system: different scenarios starring the same actor?

tPA promotes ADAMTS-4-induced CSPG degradation, thereby enhancing neuroplasticity following spinal cord injury